Ventyx Biosciences Executive Compensation Details
| Field | Detail |
|---|---|
| Company | Ventyx Biosciences, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Ventyx exec comp details out - check equity awards for 2024.
AI Summary
Ventyx Biosciences, Inc. filed its DEF 14A on April 23, 2025, detailing executive compensation and equity awards for the fiscal year ending December 31, 2024. The filing includes information on the fair value of outstanding and unvested equity awards granted in prior years, as well as awards granted and vested during the covered year.
Why It Matters
This filing provides transparency into how Ventyx Biosciences compensates its top executives, which can influence investor perception of management alignment and company strategy.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and does not present new financial risks.
Key Numbers
- 2024 — Fiscal Year (Executive compensation data pertains to this year.)
- 2023 — Fiscal Year (Some compensation data also references this prior year.)
Key Players & Entities
- Ventyx Biosciences, Inc. (company) — Filer
- 0000950170-25-057384 (filing_id) — Accession Number
- 20250423 (date) — Filing Date
- 20250604 (date) — Period of Report
- 1231 (date) — Fiscal Year End
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes and provides detailed information about matters to be voted on at a shareholder meeting, including executive compensation, director elections, and other corporate governance issues.
When was Ventyx Biosciences, Inc.'s DEF 14A filed?
Ventyx Biosciences, Inc.'s DEF 14A was filed on April 23, 2025.
What period does the executive compensation information in this filing cover?
The filing covers the fiscal year ending December 31, 2024, with some references to prior years such as 2023 and 2022 for comparative data on equity awards.
What type of compensation details are typically found in a DEF 14A filing for a company like Ventyx Biosciences?
DEF 14A filings typically detail executive compensation, including base salary, bonuses, stock awards, option awards, and other benefits for named executive officers, as well as information on equity compensation plans.
What is the SIC code for Ventyx Biosciences, Inc.?
The Standard Industrial Classification (SIC) code for Ventyx Biosciences, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 23, 2025 regarding Ventyx Biosciences, Inc..